SAFETY AND EFFICACY OF REGORAFENIB IN JAPANESE PATIENTS WITH METASTATIC COLORECTAL CANCER: A SUBGROUP ANALYSIS OF THE PHASE III CORRECT TRIAL

被引：0
|
作者：
Yamada, Y.
Yoshino, T. [1 ]
Komatsu, Y. [2 ]
Yamazaki, K. [3 ]
Tsuji, A. [4 ]
Ura, T. [5 ]
Grothey, A. [6 ]
Van Cutsem, E. [7 ]
Wagner, A. [8 ]
Ohtsu, A. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[2] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[3] Shizuoka Canc Ctr, Shizuoka, Japan
[4] Kochi Hlth Sci Ctr, Kochi, Japan
[5] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[6] Mayo Clin Rochester, Rochester, MN USA
[7] Univ Hosp Gasthuisberg, Gasthuisberg, Belgium
[8] Bayer Pharma AG, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt459.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of regorafenib (REG) in Italian patients: Subgroup analysis of the phase III CORRECT study in metastatic colorectal cancer (mCRC)
    Sobrero, Alberto F.
    Falcone, Alfredo
    Barone, Carlo
    Zaniboni, Alberto
    Clardlello, Fortunato
    Luppi, Gabriela
    Carteni, Giacomo
    Carpani, Daniela
    Curzlo, Daniela
    Boni, Corrado
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
    Takayuki Yoshino
    Yoshito Komatsu
    Yasuhide Yamada
    Kentaro Yamazaki
    Akihito Tsuji
    Takashi Ura
    Axel Grothey
    Eric Van Cutsem
    Andrea Wagner
    Frank Cihon
    Yoko Hamada
    Atsushi Ohtsu
    Investigational New Drugs, 2015, 33 : 740 - 750
  • [3] Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
    Yoshino, Takayuki
    Komatsu, Yoshito
    Yamada, Yasuhide
    Yamazaki, Kentaro
    Tsuji, Akihito
    Ura, Takashi
    Grothey, Axel
    Van Cutsem, Eric
    Wagner, Andrea
    Cihon, Frank
    Hamada, Yoko
    Ohtsu, Atsushi
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (03) : 740 - 750
  • [4] Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)
    Van Cutsem, Eric
    Sobrero, Alberto F.
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Wagner, Andrea
    Laurent, Dirk
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Regorafenib in progressive metastatic colorectal cancer (mCRC): Analysis of age subgroups in the phase III CORRECT trial
    Vogel, A.
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Falcone, A.
    Ychou, M.
    Humblet, Y.
    Buchet, O.
    Mineur, L.
    Barone, C.
    Adenis, A.
    Tabernero, J.
    Yoshino, T.
    Lenz, H-J
    Goldberg, R. M.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONKOLOGIE, 2013, 36 : 69 - 70
  • [6] Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
    Xu, Jianming
    Xu, Rui-Hua
    Qin, Shukui
    Pan, Hongming
    Bai, Yuxian
    Chi, Yihebali
    Wang, Liwei
    Bi, Feng
    Cheng, Ying
    Liu, Tianshu
    Ma, Dong
    Shen, Lin
    Ba, Yi
    Liang, Jun
    Wang, Xin
    Yau, Thomas C. C.
    Ma, Brigette B.
    Yeh, Kun-Huei
    Lin, Jen-Kou
    Kappeler, Christian
    Shapiro, Jo Ann
    Kalmus, Joachim
    Li, Jin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (08) : 1307 - 1316
  • [7] Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study
    Falcone, A.
    Van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S546 - S546
  • [8] Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study
    Karthaus, M.
    Falcone, A.
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 39 - 39
  • [9] Regorafenib (REG) in progressive metastatic colorectal cancer (mCRC): Analysis of age subgroups in the phase III CORRECT trial
    van Cutsem, Eric
    Sobrero, Alberto
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Argiles, Guillem
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Wagner, Andrea
    Laurent, Dirk
    Cupit, Lisa
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] PHASE 3 CORRECT TRIAL OF REGORAFENIB IN METASTATIC COLORECTAL CANCER (MCRC)
    Sobrero, Alberto
    Grothey, Axel
    Van Cutsem, Eric
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz Joseph
    Goldberg, Richard
    Sargent, Daniel
    Cihon, Frank
    Jeffers, Michael
    Wagner, Andrea
    Laurent, Dirk
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 16
12345